Nvidia Just Partnered With A Weight-Loss Giant, But It's Not About Pills - NVIDIA (NASDAQ:NVDA), Novo Nordisk (NYSE:NVO), IQVIA Hldgs (NYSE:IQV)

Nvidia Just Partnered With A Weight-Loss Giant, But It's Not About Pills - NVIDIA (NASDAQ:NVDA), Novo Nordisk (NYSE:NVO), IQVIA Hldgs (NYSE:IQV)

Founder and CEO of Nvidia Corp (NASDAQ:NVDA), Jensen Huang, announced on Wednesday that the company has inked two new large partnerships to advance its work in healthcare. The first is with European-based weight loss drug maker Novo Nordisk A/S (NYSE:NVO) to accelerate drug discovery and development efforts by leveraging an existing partnership with the Danish Centre for AI Innovation's (DCAI) Gefion AI supercomputer. Also Read: Hyperfine, Nvidi…

NVIDIA Partners With Novo Nordisk and DCAI to Advance Drug Discovery

Leading Global Pharma Joins Danish Enterprises, Startups and Public Health Systems Using AI Factories to Improve Drug Discovery and Healthcare...

Sofinnova taps NVIDIA to bolster portfolio companies’ computational power

Sofinnova Partners has partnered with NVIDIA in a move intended to equip its life sciences portfolio companies with faster processing speeds for processing complex biological datasets.The post Sofinnova taps NVIDIA to bolster portfolio companies’ computational power appeared first on Medical Device Network.

Novo Nordisk Amps Up Drug Discovery with Gefion AI Supercomputer

What You Should Know: –DCAI today announced that Novo Nordisk has become a customer of the Gefion AI supercomputer. – Through this agreement, Novo Nordisk will gain access to Gefion’s unparalleled computational capabilities to process vast datasets, with a goal of transforming drug discovery and development as well as driving healthcare innovation.  AI-Powered Supercomputing Alliance to Advance Drug Discovery at Scale In a landmark multiyear agr…

Sofinnova Partners collaborates with NVIDIA to accelerate European life sciences startups – Optimum Strategic CommunicationsLink to: Hot topic: Science in the time of TikTokScroll to top

Delivers high-performing AI infrastructure through NVIDIA DGX Cloud Lepton to portfolio companies, creating a powerful competitive advantage in $100B+ life sciences market BioCorteX, Bioptimus, Cure51, and Latent Labs among first cohort of startups to gain GPU capacity credits, helping position Europe at forefront of AI-driven drug discovery revolution PARIS, France – June, 11, 2025 – […]

Nvidia Announces Massive New Initiatives in Pharma And Clinical Research – RamaOnHealthcare

Founder and CEO of Nvidia, Jensen Huang, announced today in his GTC Paris keynote that the company has inked two new large partnerships to advance the company’s work in healthcare and life-sciences.The first is with European based global pharmaceutical giant, Novo Nordisk, to advance drug discovery and development efforts by leveraging an existing partnership with [...]